Kimberly Nearing Email and Phone Number
Kimberly Nearing work email
- Valid
- Valid
Kimberly Nearing personal email
- Valid
I am a highly effective and versatile professional with 20 years of international experience in life sciences (biotech and health-tech) across operations, investment banking, venture capital, and advisory roles with Fortune 500 companies and startups.Currently, I serve as a Venture Partner at BVCF Management, leading cross-border investing, due diligence, risk management, and managing global LP relationships. Additionally, I am the Chief Business Officer for three private companies (two biotech and one healthcare AI/ML), where I drive business strategy, fundraising, and business development campaigns. I also hold a Board of Directors position, serving on the Executive and Finance and Audit Committees of a Foundation in Washington, DC.A CEO recently said, “Kim’s like an investigative journalist, and I know because I was one. Her ability to connect with people from all walks of life, and uncover hidden information and ideas, coupled with her expertise in analyzing and communicating complex investment themes, and her persistence, makes her a standout. This strength has been pivotal in establishing trust and securing global opportunities that others often miss.”Key Accomplishments:• Raised over $1 billion in capital for both funds and companies as an investment banker, securing investments from the U.S., Asia, and the Middle East.• Originated and cultivated a pipeline of over 2,000 international investors, including venture capitalists, hedge funds, family offices, institutions, endowments, pension funds, and high-net-worth individuals.• Established and built successful investment banking practices in Hong Kong, Shanghai, and Beijing.• Elected to an elite 20-person executive team tasked with developing IBM’s global healthcare strategy.• Contributed to the commercialization launch teams for two new products at Amgen.Skills & Expertise:• Governance• Operations• Strategic Thinking & Problem Solving• Finance: Fundraising & Investor Relations; Financial Analysis & Modeling• Global Business Development• Due Diligence and Risk Management• Marketing: Commercialization; IR/PR; Opening New MarketsPersonal Attributes:• Diplomatic Leader & Team Builder• Entrepreneurial Mindset• Cultural Bridge Builder• Communication Skills• Versatile & Resourceful• Trustworthiness• Perpetual Learner: Within the past 12 months, earned certificates in: Fundamentals in Machine Learning for Healthcare, Evaluation of AI Applications in Healthcare (Stanford); Prompt Engineering; Digital Strategy and Business Opportunity; Cyber Security Fundamentals
Asedasciences®
View-
Venture Partner I Investment TeamBvcf Management Ltd. Nov 2019 - PresentBVCF Management Ltd., founded in 2005 by visionary leaders with strong academic ties to Harvard University, is a dynamic global investment firm focused on the life sciences and healthcare sectors. With nearly two decades of experience, BVCF is known for identifying and backing transformative companies poised to reshape the future of healthcare. Its portfolio includes high-impact investments in cutting-edge companies like BioNTech, solidifying BVCF’s position at the forefront of healthcare innovation.The firm’s investment philosophy centers on partnering with talented entrepreneurs and scientists who are developing pioneering solutions in biotech, pharmaceuticals, and medical technology. BVCF’s global reach and extensive network allow it to unlock opportunities for portfolio companies across multiple geographies, enabling growth and success in competitive markets.Driven by a passion for innovation and excellence, BVCF is more than an investor—it is a catalyst for meaningful change in the healthcare landscape, fostering groundbreaking technologies that address significant global challenges.
-
Founder & Managing PartnerApotheosis Ventures (Fractional Chief Business Officer Firm) 2019 - PresentAt Apotheosis Ventures, we provide fractional Chief Business Officer (CBO) advisory services uniquely tailored to biotech, life sciences, and health tech companies. Our experienced partners bring decades of expertise in business development, capital raising, IPO preparation, and strategic partnerships. We work closely with CEOs and executive teams to unlock value, accelerate growth, and position companies for success across global markets.Expert Services that Deliver Results - Full suite of services designed to help life sciences companies navigate challenges and seize new opportunities:• Capital Formation: From Series A funding to IPO readiness, we develop financing strategies, cultivate relationships with institutional investors, and engage analysts and family offices across the U.S., Europe, and Asia.• Business Development & Strategy: We design and execute global strategies aligned with client goals, including out-licensing, M&A, and asset spinouts. Our network opens doors to high-value partnerships.• Investor Relations & Marketing: We refine corporate messaging and create compelling narratives to boost visibility within the investment community and the biopharmaceutical industry, ensuring clients are top of mind for key decision-makers.• Governance & Risk Management: We provide governance advice and risk management frameworks, often collaborating with boards to ensure compliance and drive sustainable growth.DifferentiationIn today’s life sciences landscape, securing funding, expanding into new markets, and managing regulatory complexities are critical but challenging. We don’t just offer advisory services—we become trusted partners. Whether leading a fundraising round or preparing for an IPO, we remain laser-focused on helping clients achieve their goals. With a global network in the U.S., Europe, and Asia, we help companies secure pivotal partnerships and capital, positioning them for long-term success.
-
Business AdvisorAsedasciences® Jul 2024 - PresentSchindellegi, ChAsedaSciences is a pioneering innovator at the intersection of chemistry, biology, machine learning and data visualization, providing an integrated platform to support global efforts by scientists to develop safer chemicals. Their 3RnD platform provides cutting-edge solutions that empower researchers across diverse disciplines to translate complex data into rapid decisions, improving productivity. With a dedication to data quality, rigorous validation and collaboration, AsedaSciences is committed to advancing scientific discovery and driving meaningful impact in the global research community.
-
Chief Business Officer I Angel InvestorExpression Therapeutics, Inc. Jan 2020 - PresentTucker, Georgia, UsExpression Therapeutics is a biotechnology company focused on developing gene and protein-based therapies for rare diseases and cancer, with an emphasis on addressing unmet medical needs in hemophilia and oncology. The company leverages proprietary technologies to enhance therapeutic efficacy and improve patient outcomes, targeting multi-billion-dollar markets. In addition to its innovative therapeutic platforms, Expression Therapeutics has established its own manufacturing facility, positioning it for streamlined production and scalability. With near-term revenue potential, the company is well-positioned to make a significant impact in the biopharma sector through its cutting-edge therapies and operational capabilities. Backed by a highly experienced team with deep expertise in biotechnology, gene therapy, and oncology, and with strong connections to Emory University, Expression Therapeutics is at the forefront of advancing novel treatments. -
Chief Business OfficerMaverix Oncology, Inc. May 2018 - PresentPalo Alto, California, UsMaveriX Oncology is a biotechnology company based in Palo Alto, California, focused on developing innovative, targeted small-molecule therapeutics for the treatment of solid tumors. The company's proprietary platform, Conditionally Activated-Small Molecule Drug Conjugates (CA-SMDC), is designed to selectively kill cancer cells while minimizing impact on healthy tissues by exploiting unique metabolic conditions in the tumor microenvironment. MaveriX aims to address unmet clinical needs, particularly in cancers that are resistant to chemotherapy and immunotherapy, with their lead candidates targeting both early-stage and metastatic solid tumors. By integrating AI-driven design, the company accelerates the discovery of precision therapies with the potential for both monotherapy and combination therapy approaches -
Member Of The Board Of Directors I Executive Committee I Finance And Audit CommitteeThe Rostropovich-Vishnevskaya Foundation Sep 2017 - PresentWashington, District Of Columbia, UsRVF (Rostropovich-Vishnevskaya Foundation) is a global development organization that promotes the health and well being of children in need through partnerships that create sustainable, transformational public health programs. RVF’s Chairman is Ambassador Thomas Pickering, former ambassador to the United Nations. Honorary Advisory Board members include President & Mrs. Jimmy Carter; Her Majesty Queen Sofia of Spain; His Royal Highness, Charles, Prince of Wales; Her Royal Highness Princess Irene of Greece.Supporters and Partners include the Bill & Melinda Gates Foundation; Teresa & H. John Heinz III Charitable Fund; The Marjorie Merriweather Post Foundation; Vira Heinz Foundation; Zayed Bin Sultan Al Nahayan Charitable and Humanitarian Foundation; Pfizer; GlaxoSmith Kline; Merck; Government of Japan; and the National Institute of Health, Norway. -
Chief Business OfficerElpiscience Biopharmaceuticals, Inc. Jul 2021 - Jul 2023Shanghai, Shanghai, CnElpiscience Biopharmaceuticals is a clinical-stage company focused on developing innovative immuno-oncology therapies to treat cancer. Founded in 2017 and headquartered in Shanghai, China, the company is advancing a pipeline of novel molecules that target the tumor microenvironment to enhance the immune system's ability to fight cancer. Their lead candidates, including anti-CD39 monoclonal antibody ES002, aim to transform “cold” tumors into “hot” ones, overcoming resistance to existing therapies. Elpiscience is led by experienced industry professionals, such as co-founders Xiaohui Ji, Ph.D., and Hongtao Lu, Ph.D., and is backed by prominent investors like Lilly Asia Ventures and Hillhouse Capital -
Member Of The Board Of DirectorsThe Bayhelix Group Jan 2019 - Dec 2021San Francisco, Ca, UsBoard of Directors: 2019 - PresentRegional Head of NY/NJ/PA: 2018 - PresentMember: 2017 - PresentThe BayHelix Group is an influential invitation-only professional organization of Chinese business leaders shaping the future of the healthcare and life sciences industry in China. Founded in 2001 in the San Francisco Bay Area, BayHelix has grown to hundreds of members globally with a strong presence in China and the US. Members include executives of many of the world’s top pharmaceutical and biopharmaceutical companies, venture capital firms, as well as CEOs of private companies in China and the US. BayHelix is a excellent entry point for western business people and investors wanting to expand into the Greater China region. -
Senior Managing Director, Group Head Life SciencesCedrus Group May 2006 - Dec 2019Cedrus Group is a global investment holding company with expertise in Asset Management, Private Wealth Management, and Investment Banking. The firm is led by seasoned investment management professionals who have held senior-level positions at some of the world’s largest investment firms and have decades of international experience including in the US, China, Asia and the Middle East. Strategically headquartered in Hong Kong, Shanghai, Beijing, Shenzhen, Hainan and Zurich.
-
Managing DirectorPhoenician Venture Partners 2003 - 2006Growth stage biotech company. Raised $250 million to support per-IPO companies. Then, the IPO window closed.
-
Business Development Executive I Executive CommitteeIbm Healthcare Group 2001 - 2003IBM's Healthcare group focuses on leveraging advanced technologies such as AI, cloud computing, and quantum computing to drive transformation across the healthcare industry. Their offerings include AI-powered solutions that improve clinical workflows, enhance patient care, and streamline operational efficiency for healthcare providers, payers, and life sciences organizations. Through collaborations with institutions like Cleveland Clinic, IBM has pioneered efforts in healthcare research using quantum computing to address complex medical challenges. IBM also offers consulting services for healthcare providers, helping modernize hospitals and implement digital strategies for better patient outcomes. Recently, IBM sold its Watson Health assets to Francisco Partners, signaling a shift in its healthcare strategy
-
Senior Product Manager I Business Development, Special Projects GroupAmgen 1994 - 2000Thousand Oaks, Ca, UsAmgen, founded in 1980, is one of the world’s largest biotechnology companies, specializing in the development of innovative therapeutics to treat serious illnesses such as cancer, cardiovascular disease, and osteoporosis. Headquartered in Thousand Oaks, California> Business Development, Special Projects Group - Worked alongside VP to identify innovative business opportunities, particularly in healthcare IT> Senior Product Marketing Manager - Served on 2 product commercialization launch teams and leading blockbuster product marketing team
Kimberly Nearing Skills
Kimberly Nearing Education Details
-
Harvard UniversityMasters Of Science With Honors -
University Of MichiganB.A. In Economics With Honors
-
The Wharton School(Certificate) Pharmaceutical & Biotechnology Executive Management
Frequently Asked Questions about Kimberly Nearing
What company does Kimberly Nearing work for?
Kimberly Nearing works for Asedasciences®
What is Kimberly Nearing's role at the current company?
Kimberly Nearing's current role is Venture Partner I Chief Business Officer I Board Director - Fundraising I Business Development I Investor Relations I Deal Sourcing I Commercialization - U.S. I Asia I GCC Region - Life Sciences I Biotech I HealthTech.
What is Kimberly Nearing's email address?
Kimberly Nearing's email address is ki****@****ail.com
What schools did Kimberly Nearing attend?
Kimberly Nearing attended Harvard University, University Of Michigan, The Wharton School.
What skills is Kimberly Nearing known for?
Kimberly Nearing has skills like Start Ups, Business Strategy, Strategic Partnerships, Business Development, Strategic Planning, Marketing Strategy, Biotechnology, Venture Capital, Mergers And Acquisitions.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial